Table 4.
Univariate Analysis of Text Platform Use
| Low Platform Use (N=11)  | 
High Platform Use (N=10)  | 
P-value | |
|---|---|---|---|
| Age* | 52.3 ± 11.6 | 51.9 ± 14.4 | 0.949 | 
| Number of Texts* | 4.6 ± 2.2 | 20.1 ± 11.8 | <0.001 | 
| Gender | 1.0 | ||
| Male | 6 (54.5%) | 5 (50%) | |
| Female | 5 (45.5%) | 5 (50%) | |
| Marital Status | 0.004 | ||
| Married | 11 (100%) | 4 (40%) | |
| Not Married | 0 | 6 (60%) | |
| Race | 0.393 | ||
| Caucasian | 7 (63.6%) | 5 (50%) | |
| Hispanic/Latino | 1 (9.1%) | 4 (40%) | |
| Black or African | 1 (9.1%) | 1 (10%) | |
| Native American | 1 (9.1%) | 0 | |
| Prefer not to answer | 1 (9.1%) | 0 | |
| Insurance Status | 0.765 | ||
| Privately Insured | 9 (81.8%) | 7 (70%) | |
| Medicaid/Medicare | 1 (9.1%) | 2 (20%) | |
| Uninsured | 0 | 0 | |
| Other | 1 (9.1%) | 1 (10%) | |
| Employment Status? | 0.363 | ||
| Currently Employed | 5 (45.5%) | 6 (60%) | |
| Currently Unemployed | 2 (18.2%) | 0 | |
| Retired | 4 (36.4%) | 3 (30%) | |
| Other | 0 | 1 (10%) | |
| Highest Education level? | 0.263 | ||
| Less than HS diploma | 1 (9.1%) | 1 (10%) | |
| HS diploma | 4 (36.4%) | 3 (30%) | |
| Some College | 4 (36.4%) | 3 (30%) | |
| BA, BS, or other degree | 0 | 3 (30%) | |
| Graduate Education | 2 (18.2%) | 0 | |
| Yearly Income | 0.188 | ||
| 0–10k | 1 (9.1%) | 0 | |
| 11–20k | 0 | 2 (20%) | |
| 21–40k | 3 (27.3%) | 5 (50%) | |
| 41–60k | 1 (9.1%) | 2 (20%) | |
| >60k+ | 5 (45.5%) | 1 (10%) | |
| No answer | 1 (9.1%) | 0 | |
| Tobacco Use | 0.561 | ||
| Current User | 0 | 1 (10%) | |
| Former User | 5 (45.5%) | 4 (40%) | |
| Never User | 6 (54.5%) | 5 (50%) | |
| Alcohol Use | 0.279 | ||
| Current User | 4 (36.4%) | 6 (60%) | |
| Former User | 0 | 0 | |
| Never User | 7 (63.6%) | 4 (40%) | |
| Illicit Drug Use | 1.0 | ||
| Current User | 0 | 0 | |
| Former User | 0 | 0 | |
| Never User | 11 (100%) | 10 (100%) | |
| H&N Cancer Site | 0.249 | ||
| Benign/Other | 2 (18.2%) | 3 (30%) | |
| Oropharynx cancer | 3 (27.3%) | 4 (40%) | |
| Thyroid Cancer | 2 (18.2%) | 1 (10%) | |
| Salivary Gland Cancer | 0 | 2 (20%) | |
| Oral cavity cancer | 2 (18.2%) | 0 | |
| Skin cancer | 2 (18.2%) | 0 | |
| Paranasal/nasal cavity | 0 | 0 | |
| Larynx Cancer | 0 | 0 | |
| Surgery | 0.113 | ||
| Trans-oral robotic surgery | 2 (18.2%) | 0 | |
|   Open resection w/ free flap reconstruction  | 
2 (18.2%) | 0 | |
|   Open resection and/or neck dissection  | 
6 (54.5%) | 10 (100%) | |
| Minor Procedure/Other | 1 (9.1%) | 0 | |
| Post-Op Complications | 0.012 | ||
| No | 11 (100%) | 5 (50%) | |
| Yes | 0 | 5 (50%) | 
mean ± standard deviation